| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |